Literature DB >> 8462227

Drug concentration monitoring. An approach to rational use.

G R Brown1, M Miyata, J P McCormack.   

Abstract

Mesh:

Year:  1993        PMID: 8462227     DOI: 10.2165/00003088-199324030-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  8 in total

Review 1.  A critical reevaluation of the "therapeutic range" of aminoglycosides.

Authors:  J P McCormack; P J Jewesson
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  The value of therapeutic drug monitoring to the practising physician--an hypothesis needing sensible application.

Authors:  I D Watson; A H Thomson
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

3.  The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.

Authors:  G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 4.  Kinetics of drug effects in man.

Authors:  B Oosterhuis; C J van Boxtel
Journal:  Ther Drug Monit       Date:  1988       Impact factor: 3.681

Review 5.  Therapeutic drug monitoring.

Authors:  R Spector; G D Park; G F Johnson; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1988-04       Impact factor: 6.875

6.  Individualizing gentamicin dosage regimens in burn patients with gram-negative septicemia: a cost--benefit analysis.

Authors:  J L Bootman; A I Wertheimer; D Zaske; C Rowland
Journal:  J Pharm Sci       Date:  1979-03       Impact factor: 3.534

Review 7.  Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Authors:  J L Bauman; M D Schoen; T J Hoon
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

  8 in total
  2 in total

1.  Caffeine Therapeutic Drug Monitoring Is Necessary and Cost-effective.

Authors:  Peter Gal
Journal:  J Pediatr Pharmacol Ther       Date:  2007-10

Review 2.  Newer antiepileptic drugs. Towards an improved risk-benefit ratio.

Authors:  P N Patsalos; J W Sander
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.